Stay updated on IBI310 Combo vs Sorafenib in HCC Clinical Trial

Sign up to get notified when there's something new on the IBI310 Combo vs Sorafenib in HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IBI310 Combo vs Sorafenib in HCC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Recruitment status updated to no longer looking for participants. The history now includes a new revision entry (v3.6.0) to document this update.
    Difference
    0.4%
    Check dated 2026-06-12T14:59:03.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The history now includes a new entry for Revision: v3.5.5, and the previous Revision: v3.5.4 entry has been removed, reflecting a small platform update to the record history display.
    Difference
    0.1%
    Check dated 2026-06-05T10:35:04.000Z thumbnail image
  3. Check
    22 days ago
    No Change Detected
  4. Check
    29 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The page's revision tag moved from v3.5.3 to v3.5.4, indicating a new version of the record history. This reflects an update to the page's metadata rather than changes to the underlying study data.
    Difference
    0.1%
    Check dated 2026-05-14T22:55:14.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The Record History shows the latest revision updated to v3.5.3, replacing the previous v3.5.2. This indicates a new version of the study record has been published.
    Difference
    0.1%
    Check dated 2026-04-30T17:31:15.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added to the record history, and revision v3.5.0 was removed.
    Difference
    0.1%
    Check dated 2026-04-16T10:40:06.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Revision v3.5.0 adds Study Status, Contacts/Locations, and Study Design and marks the study as Completed; the prior update removed the Recruiting status and sponsor Innovent Biologics (Suzhou) Co. Ltd.
    Difference
    2%
    Check dated 2026-03-25T20:54:51.000Z thumbnail image

Stay in the know with updates to IBI310 Combo vs Sorafenib in HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IBI310 Combo vs Sorafenib in HCC Clinical Trial page.